News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
41,652 Results
Type
Article (2436)
Company Profile (14)
Press Release (39202)
Section
Business (11539)
Career Advice (18)
Deals (1608)
Drug Delivery (3)
Drug Development (9944)
Employer Resources (4)
FDA (643)
Job Trends (1098)
News (22212)
Policy (1290)
Tag
Academia (179)
Accelerated approval (1)
Adcomms (1)
Allergies (51)
Alliances (3340)
ALS (9)
Alzheimer's disease (76)
Antibody-drug conjugate (ADC) (30)
Approvals (652)
Artificial intelligence (27)
Autoimmune disease (1)
Automation (1)
Bankruptcy (18)
Best Places to Work (1037)
Biosimilars (8)
Biotechnology (12)
Bladder cancer (40)
Brain cancer (7)
Breast cancer (72)
Cancer (773)
Cardiovascular disease (3)
Career advice (17)
CAR-T (67)
Cell therapy (136)
Cervical cancer (6)
Clinical research (7984)
Collaboration (103)
Compensation (35)
Complete response letters (1)
COVID-19 (149)
CRISPR (3)
C-suite (27)
Data (373)
Diabetes (9)
Diagnostics (276)
Drug discovery (11)
Duchenne muscular dystrophy (3)
Earnings (4403)
Employer branding (1)
Employer resources (4)
Events (9443)
Executive appointments (58)
FDA (749)
Frontotemporal dementia (1)
Funding (67)
Gene editing (9)
Gene therapy (24)
GLP-1 (28)
Government (168)
Grass and pollen (4)
Guidances (6)
Healthcare (1596)
IgA nephropathy (2)
Immunology and inflammation (16)
Indications (6)
Infectious disease (161)
Inflammatory bowel disease (8)
Influenza (4)
Intellectual property (11)
Interviews (3)
IPO (1045)
IRA (1)
Job creations (103)
Job search strategy (16)
Kidney cancer (1)
Labor market (1)
Layoffs (21)
Legal (118)
Liver cancer (26)
Lung cancer (118)
Lymphoma (43)
Machine learning (2)
Management (2)
Manufacturing (17)
MASH (2)
Medical device (110)
Medtech (110)
Mergers & acquisitions (603)
Metabolic disorders (17)
Multiple sclerosis (10)
Neurodegenerative disease (7)
Neuroscience (108)
NextGen: Class of 2025 (343)
Non-profit (218)
Obesity (3)
Opinion (17)
Ovarian cancer (31)
Pain (2)
Pancreatic cancer (17)
Parkinson's disease (4)
Partnered (1)
Patents (23)
Patient recruitment (20)
Peanut (38)
People (3605)
Pharmaceutical (2)
Phase I (3594)
Phase II (3627)
Phase III (2101)
Pipeline (178)
Policy (5)
Postmarket research (82)
Preclinical (1314)
Press Release (15)
Prostate cancer (20)
Radiopharmaceuticals (14)
Rare diseases (7)
Real estate (189)
Recruiting (1)
Regulatory (1179)
Reports (5)
Research institute (340)
Resumes & cover letters (1)
RSV (1)
Schizophrenia (1)
Series A (10)
Series B (5)
Sickle cell disease (1)
Spinal muscular atrophy (1)
Sponsored (3)
Startups (210)
Stomach cancer (3)
Supply chain (2)
The Weekly (3)
Vaccines (73)
Venture capitalists (4)
Weight loss (2)
Women's health (2)
Date
Today (13)
Last 7 days (89)
Last 30 days (326)
Last 365 days (3486)
2025 (1206)
2024 (3801)
2023 (4116)
2022 (4846)
2021 (4878)
2020 (4230)
2019 (3271)
2018 (2421)
2017 (2881)
2016 (2367)
2015 (2712)
2014 (1510)
2013 (648)
2012 (547)
2011 (458)
2010 (335)
Location
Africa (19)
Alabama (3)
Arizona (10)
Asia (3188)
Australia (603)
California (694)
Canada (193)
China (125)
Colorado (23)
Connecticut (12)
Delaware (22)
Europe (7610)
Florida (95)
Georgia (16)
Idaho (6)
Illinois (34)
India (4)
Indiana (5)
Iowa (2)
Japan (12)
Kansas (12)
Kentucky (1)
Maine (2)
Maryland (128)
Massachusetts (406)
Michigan (5)
Minnesota (4)
Missouri (7)
Montana (8)
New Jersey (304)
New Mexico (1)
New York (214)
North Carolina (36)
North Dakota (7)
Northern California (265)
Ohio (3)
Oregon (4)
Pennsylvania (151)
Rhode Island (3)
South America (26)
South Carolina (1)
Southern California (317)
Tennessee (6)
Texas (131)
United States (2395)
Utah (3)
Virginia (20)
Washington D.C. (1)
Washington State (88)
41,652 Results for "etherna immunotherapies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
etherna Announces Strategic Multi-Target Collaboration with Dropshot Therapeutics
January 9, 2025
·
2 min read
Antonin (Tony) de Fougerolles appointed as new Chair of etherna
July 10, 2024
·
3 min read
Almirall and etherna Enter Into a Multi-Target Alliance to Develop mRNA-based Therapies in Medical Dermatology
Almirall, S.A., a global pharmaceutical company focused on medical dermatology, and etherna, an mRNA/LNP technology platform company, announced a multi-target alliance to discover and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer.
December 12, 2023
·
4 min read
Business
mRNA/LNP technology platform company etherna names Bernard Sagaert as Chief Executive Officer and Marijn Dekkers as Chairman of the Board
etherna, a leading mRNA/LNP technologies company, announced that Bernard Sagaert has been confirmed-as Chief Executive Officer.
October 17, 2023
·
4 min read
Business
Steffen Helmling joins etherna as Chief Business Officer
etherna announced today that Steffen Helmling, PhD has been appointed Chief Business Officer.
June 8, 2023
·
2 min read
Business
Money on the Move: AdvanCell, eTheRNA, Bluejay and More
Money is now flowing into promising platforms for prostate cancer from AdvanCell, mRNA therapeutics from eTheRNA, hepatitis from Bluejay and more.
August 24, 2022
·
5 min read
·
Tristan Manalac
eTheRNA Announces Relocation and Expansion of R&D Facility
eTheRNA immunotherapies NV, an mRNA technology discovery and development company with a full platform of integrated capabilities, is pleased to announce the relocation of its R&D group to a new and larger site in Gent, Belgium.
April 5, 2022
·
1 min read
eTheRNA Immunotherapies to Host Key Opinion Leader Webinar on mRNA-Lipid Nanoparticles for Cancer ImmunotherapyWednesday, March 2 at 10am ET / 3pm GMT / 4pm CET
eTheRNA immunotherapies NV (‘eTheRNA’), an mRNA technology discovery and development company with a full platform of integrated capabilities, today announced that it will host a key opinion leader (KOL) webinar on mRNA-lipid nanoparticles (LNP) for cancer immunotherapy on Wednesday, March 2, 2022 at 10am ET / 3pm GMT / 4pm CET.
February 28, 2022
·
1 min read
Press Releases
Positive Adherence Impact of IPUMP® Connected Assistant for Sublingual Liquid Allergen Immunotherapy Treatment
April 14, 2025
·
4 min read
Press Releases
Vicero Welcomes Renowned Cancer Immunotherapy Experts to its Scientific Advisory Board
March 24, 2025
·
4 min read
1 of 4,166
Next
